Responses
Other content recommended for you
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Improving the environmental sustainability of paediatric care
- Towards net zero: asthma care
- Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
- Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
- Is the path to greener inhalers paved with good intentions?
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Turning green: the impact of changing to more eco-friendly respiratory healthcare – a carbon and cost analysis of Dutch prescription data